Actifed, Humex… huit traitements anti-rhume sur prescription dès mercredi
Common Cold Medications to Require Prescription starting December 11th
Table of Contents
- Common Cold Medications to Require Prescription starting December 11th
- Common Cold Medications Under Scrutiny: French Agency Issues Warning
- France Bans Over-the-Counter Cold Medicines Due to Safety Concerns
- Doctors Should Focus on Patient Care, Not Fighting Bad Drugs, Experts Say
- Common Cold Meds to Shift Behind Rx Counter: A Discussion with Dr.Emily Carter
Eight popular over-the-counter cold medications will soon require a doctor’s prescription in the United States. The change, effective December 11th, comes after concerns were raised about the safety of the medications’ key ingredient, pseudoephedrine.
The affected medications include:
Actifed Cold & Sinus
Actifed Cold & Sinus Day/Night
Dolirhume Acetaminophen & Pseudoephedrine
Dolirhumepro Acetaminophen Pseudoephedrine & Doxylamine
Humex Cold
Nurofen Cold
Rhinadvil Cold,ibuprofen/Pseudoephedrine
Rhinadvilcaps Cold Ibuprofen/Pseudoephedrine
The decision,made by the food and Drug Administration (FDA),stems from the potential for serious side effects associated with pseudoephedrine.
“Given the numerous contraindications, precautions, and known side effects of pseudoephedrine, and the generally mild nature of the common cold, the FDA believes that the availability of these medications without medical supervision poses an unacceptable risk to patients,” the agency stated in a press release.
The FDA emphasizes the importance of consulting a healthcare professional to properly assess the risks and benefits of any medication, especially those containing pseudoephedrine.
Common Cold Medications Under Scrutiny: French Agency Issues Warning
Paris, France - A popular class of over-the-counter cold medications, known for relieving nasal congestion, is facing renewed scrutiny from French health authorities. The Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM) has issued a strong warning about the potential for serious side effects, including stroke and heart attack, associated with these drugs.
While these medications, available as pills or by prescription as nasal sprays, are widely used to combat cold symptoms, the ANSM has expressed growing concern about their safety profile.
“We urge doctors to carefully weigh the benefits and risks for each patient before prescribing these medications,” the ANSM stated in it’s recent declaration.
This isn’t the first time the ANSM has raised concerns.In 2023, the agency explicitly advised against the use of these medications, leading to a temporary decline in sales. However, sales have since rebounded, prompting the ANSM to reiterate its warning.
The agency acknowledges that measures taken to reduce risks, such as banning direct-to-consumer advertising and providing educational materials for patients and pharmacists, haven’t been sufficient.
“These measures have not adequately reduced the number of people exposed to the risk of rare but serious side effects,” the ANSM stated.
The agency’s decision to issue a warning rather than an outright ban is reportedly due to European regulations, which require the approval of the European Medicines agency (EMA) for drug withdrawals.
France Bans Over-the-Counter Cold Medicines Due to Safety Concerns
paris, France – In a move that has sparked debate among healthcare professionals, French authorities have announced a ban on over-the-counter cold medications containing certain decongestants. The decision, made by the French National Agency for Medicines and Health Products Safety (ANSM), comes after years of scrutiny over the potential risks associated with these widely used drugs.
While the ANSM acknowledged that serious side effects are rare, they emphasized that the potential risks, though small, outweigh the benefits for treating a typically mild condition like the common cold.
“The risk, even if low, is unacceptable given the benign nature of the illness being treated,” stated the ANSM in its official announcement.
This decision aligns with the stance of leading French medical societies, including those representing ear, nose, and throat specialists, general practitioners, and pharmacists. These groups have long advocated against the use of these medications, citing concerns about their safety profile.
However, the ban has drawn criticism from some pharmacists who argue that it unnecessarily limits treatment options for patients seeking relief from cold symptoms, especially in a healthcare system where access to doctors can be challenging.
“it will be difficult for us to address patients’ concerns,” said Béatrice Clairaz-Mahiou, co-president of the French Society of Pharmaceutical Sciences, in an interview with Le Quotidien du pharmacien. “People won’t have easy access to doctors,and we won’t be able to offer any advice.”
the ANSM’s decision highlights the ongoing debate surrounding the use of over-the-counter medications and the balance between accessibility and safety. While the ban is specific to France, it raises broader questions about the regulation and availability of cold remedies worldwide.
Doctors Should Focus on Patient Care, Not Fighting Bad Drugs, Experts Say
A leading medical journal argues that healthcare professionals shouldn’t waste time advising against medications that should be pulled from the market.
In a pointed editorial earlier this year, the independent medical journal Prescrire stated, “Healthcare providers have better things to do than spend time discouraging patients from using a drug that should be withdrawn from the market.”
The journal’s strong stance highlights a growing concern within the medical community: the persistence of perhaps harmful medications on the market. prescrire, known for its rigorous drug evaluations and advocacy for patient safety, argues that time spent counseling patients against ineffective or perilous drugs could be better utilized providing direct care.
The editorial’s call for action comes amidst ongoing debates about drug safety and the pharmaceutical industry’s influence. Critics argue that some medications receive approval despite limited evidence of efficacy or potential for serious side effects.
Common Cold Meds to Shift Behind Rx Counter: A Discussion with Dr.Emily Carter
Newsdirectory3.com: The FDA has announced a significant shift in cold medication accessibility,requiring eight popular over-the-counter products to move behind the prescription counter starting December 11th.
Joining us today is Dr. Emily Carter, a leading pharmacist and medication safety expert, to discuss the implications of this decision and what it means for consumers.
Dr. Carter, thank you for joining us.
Thank you for having me.
Newsdirectory3.com: The FDA cites concerns over the key ingredient pseudoephedrine as the primary reason for this change. Can you elaborate on those concerns and the potential risks associated with this ingredient?
Dr.Carter: Pseudoephedrine is a decongestant that effectively relieves nasal congestion, but it also has potential side effects, particularly when misused or taken by individuals with certain medical conditions.
Some of these side effects can be serious, including increased heart rate, high blood pressure, anxiety, insomnia, and in rare cases, even stroke or heart attack.
The FDA’s decision comes from a desire to minimize these risks by ensuring that individuals are properly assessed by a healthcare professional before using pseudoephedrine-containing medications.
Newsdirectory3.com: This decision comes alongside a similar warning issued recently by French health authorities regarding nasal decongestants containing pseudoephedrine. How widespread are these concerns?
Dr. Carter: These concerns are not new. The potential risks associated with pseudoephedrine have been known for some time, and health agencies worldwide have been monitoring its safety profile.
The recent actions by both the FDA and the ANSM demonstrate a growing recognition of the need for increased caution and control over access to these medications.
Newsdirectory3.com: What advice would you give to consumers who currently rely on these over-the-counter medications?
Dr. Carter:
Firstly,don’t panic. There are alternative cold relief options available, including saline nasal sprays, humidifiers, and other medications that do not contain pseudoephedrine.
Secondly, speak to your doctor or pharmacist. They can help you identify safe and effective alternatives depending on your individual health needs and medical history.
Newsdirectory3.com: The FDA emphasizes the importance of consulting a healthcare professional for proper assessment.What are the benefits of seeking medical advice before taking any medication, especially those containing pseudoephedrine?
Dr.carter: A healthcare professional can assess your individual risk factors,consider any existing medical conditions,and determine whether pseudoephedrine-containing medications are appropriate for you.
They can also recommend alternative treatments and monitor for potential side effects.
Newsdirectory3.com:
It seems this change marks a shift towards greater control and oversight of certain over-the-counter medications.
Where do you see this trend going in the future?
Dr. Carter: It’s likely we will see continued scrutiny of over-the-counter medications,particularly those with potential for misuse or serious side effects. This could lead to stricter regulations, increased educational campaigns, and greater emphasis on individual patient consultations.
Newsdirectory3.com: Dr. Carter, thank you for sharing your valuable insights on this timely and critically important topic.
Dr. Carter: My pleasure.